Randomized trial: AVIFAVIR for Treatment of Patients with Moderate COVID-19

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial – Clinical Infectious Diseases

Commentary on Twitter

NEW ?? #CID @IDSAInfo
AVIFAVIR(favipiravir) for Treatment of Patients with Moderate #COVID19 : Interim Results of a Phase II/III Multicenter Randomized Clinical Trial #IDTwitter https://t.co/PwUcCWu5KQ pic.twitter.com/6N6lxHUu9K

— Antibiotic Steward? Bassam Ghanem (@ABsteward) August 8, 2020